The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension
Clinical trial NCT06473493 · UNKNOWN
Trial details
- NCT number
- NCT06473493
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.